Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2024

Bispecific therapeutics: Moving into the fast lane

Beyond CD3 bispecifics: Activating NK cells, CD40, CD137

Date

27 Feb 2024

Session

Bispecific therapeutics: Moving into the fast lane

Topics

Immunotherapy

Tumour Site

Presenters

Juanita Lopez

Authors

J.S. Lopez

Author affiliations

  • Drug Development Unit, The Royal Marsden Hospital NHS Foundation Trust, SM2 5PT - Sutton/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Presenter: All Speakers

Session: Bispecific therapeutics: Moving into the fast lane

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.